Top Story

Repurposed asthma drug shows reduction in blood glucose

July 22, 2017

A subset of trial participants with type 2 diabetes showed a significant reduction in blood glucose after taking an anti-asthma drug, according to recent study findings.

In the randomized, double blind, placebo-controlled trial, some patients with type 2 diabetes responded to amlexanox (aphthasol, Uluru), an anti-inflammatory and anti-allergic drug that is used to treat asthma. Researchers conducted a molecular analysis of fat cells from the participants who showed a reduction in glucose.

Researchers detect Zika vector for the first time in Wisconsin

July 22, 2017
Researchers at the Upper Midwestern Center of Excellence in Vector Borne Diseases, a CDC-funded center to increase surveillance efforts in the Midwest, have identified…

Rutgers Cancer Institute of New Jersey appoints chief nursing officer

July 22, 2017
Janet Gordils-Perez, DNP, RN, ANP-BC, AOCNP, has been promoted to chief nursing officer at Rutgers Cancer Institute of New Jersey. Gordils-Perez — who most…
Meeting News

Arthroscopy proved safe, effective for young patients with FAI, open physis

July 22, 2017
Ortho: Arthroscopy, Pediatrics, Sports Medicine
Blog

BLOG: Three reasons cornea is the new glaucoma

July 22, 2017
Ophthalmology is a great specialty partly because procedures, devices and drugs constantly evolve, keeping us learning and giving our patients better care. Ask your…
More News Headlines »
CME

Focus on Female and Male Aesthetics

No commercial support for this activity.

Facial Aesthetics New York 2016 was an excellent opportunity to gain experienced perspective from a…
More »
CME Article

New Models of Psychiatric Consultation in the General Medical Hospital: Liaison Psychiatry Is Back

Psychiatric Annals, July 2017, Volume 47 Issue 7
Recent work has shown improved outcomes with new models of psychiatric consultation in the general medical hospital…
More »
Resource Centers
Heart in Diabetes

Heart in Diabetes

Video
Meeting News

VIDEO: Cardiologists debate CV risk predictors in patients with diabetes

July 16, 2017
More »
Advertisement
Advertisement